Conference Co-Chairs:

Beth Janeway Hallyburton

Assistant General Counsel and Head, US Government Investigations at GlaxoSmithKline (Durham, NC)

Daniel J. Moynihan

Global Compliance Officer - Life Science at MilliporeSigma, A business of Merck KGaA (Boston, MA)

Speakers:

S. Joy Dowdle

Partner at Paul Hastings LLP (Houston, TX)

Michael Dusseau

Vice President, Compliance Operations at Allergan plc (Parsippany, NJ)

Beth Janeway Hallyburton

Assistant General Counsel and Head, US Government Investigations at GlaxoSmithKline (Durham, NC)

Markus Hartmann

Vice President & North American General Counsel at Sandoz (Princeton, NJ)

James P. Loonam

Deputy Chief, Business and Securities Fraud Section at United States Attorney’s Office, E.D.N.Y.

Barry McCoy

Executive Director, Lead of Anti- Corruption Program at Merck & Co., Inc. (Philadelphia, PA)

Sandra Moser

Principal Deputy Chief at U.S. Department of Justice, Criminal Division, Fraud Section

Daniel J. Moynihan

Global Compliance Officer - Life Science at MilliporeSigma, A business of Merck KGaA (Boston, MA)

Michael C. Pacella

Vice President, Global Anti-Corruption & Investigations Counsel at Zimmer Biomet (Washington, DC)

Suzanne C. Seferian

Health Care Compliance Officer at Johnson & Johnson (Titusville, NJ)

Peter Schutzel

Division Counsel, Anti-Corruption & Global Healthcare Compliance at Abbott (Chicago, IL)

Keir Strauss

Assistant General Counsel & Global Privacy Officer at INC Research (Durham, NC)

Avi Spira

Vice President & Chief Compliance Officer at Cantel Medical Corp. (Little Falls, NJ)

Aaron Tidman

Anti-Corruption Counsel at Gilead Sciences Inc. (San Francisco, CA)

Hank Bond Walther

Partner at Jones Day (Washington, DC)